64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer. (15th May 2017) - Sasada, S.; Kurihara, H.; Kinoshita, T.; Yoshida, M.; Honda, N.; Shimoi, T.; Shimomura, A.; Yunokawa, M.; Yonemori, K.; Shimizu, C.; Hamada, A.; Kanayama, Y.; et al.